Nebenwirkungen · Enhertu
Enhertu 100 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 11
HOS-144518 · Präparat HOS-099200
Table 3: Adverse reactions in patients treated with trastuzumab deruxtecan System organ class 5.4 mg/kg monotherapy 6.4 mg/kg monotherapy 5.4 mg/kg + Frequency category Adverse reaction Adverse reaction pertuzumab Adverse reaction Infections and infestations Very common upper respiratory tract upper respiratory tract upper respiratory infectiona infectiona tract infectiona Common pneumonia pneumonia pneumonia Blood and lymphatic system disorders Very common anaemiab, anaemiab, neutropeniac, neutropeniac, thrombocytopeniad, thrombocytopeniad, thrombocytopeniad, neutropeniac, leukopeniae, anaemiab, leukopeniae lymphopeniaf leukopeniae, lymphopeniaf Common lymphopeniaf, febrile neutropenia, febrile neutropenia, pancytopeniag pancytopeniag pancytopeniag Uncommon febrile neutropenia Metabolism and nutrition disorders Very common hypokalaemiah, hypokalaemiah, hypokalaemiah, decreased appetite decreased appetite decreased appetite Common dehydration dehydration dehydration
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-20T16:27:00Z · SHA-256 3c4c744afc1ef29bbcad254e39bd7fd8b4be34bb4ddecf254258c2ab2c9863c8 · Passage fed94bfd748692e8d188429b277d2899e793217702470b50116eafc457a7f1fd · Zeichen 7923–9663 im Abschnitt